PharmaCyte Biotech, Inc. (PMCB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.06M |
| Enterprise Value | -13.54M |
| P/E Ratio | -0.15 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.13 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 2.57 |
Fiscal Year
| Fiscal Year | April 30, 2026 |
| Most Recent Quarter | April 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.42 |
| Return On Equity | -0.51 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -5.3M |
| Net Income | -19.42M |
| Diluted EPS | -2.77 |
Balance Sheet
| Total Cash | 37.08M |
| Total Cash/Share | 3.86 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 45.28 |
| Book Value Per Share | 3.64 |
Price History
| 52-Week Change | -54.99 |
| 52-Week High | 1.51 |
| 52-Week Low | 0.43 |
| Moving Average 50 Days | 0.58 |
| Moving Average 200 Days | 0.73 |
Statistics
| Average Volume | 107,730 |
| Shares Outstanding | 10.74M |
| % Held by Institutions | 10.87 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.01 |
| Last Split Factor | 1:1550 |
| Last Split Date | July 12, 2021 |
AD
